Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed Aug 10, 2026 · 10-Q · 41 days after period end · 0001091818-26-000108
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | $238.68K | -$122.78K | -$114.44K | -$113.93K |
| EPS Diluted | $0.01 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end
